Viatris stock hits 52-week high at $17.68

Viatris Inc. (VTRS) stock reached a 52-week high of $17.68, reflecting strong market performance with a 90.82% surge over the past year and a 2.78% dividend yield. The pharmaceutical company is considered undervalued by InvestingPro, with recent positive news including exceeding Q1 2026 financial expectations, successful Phase 3 clinical trials, and FDA acceptance of a new drug application for acute pain.